@article{JTD21410,
author = {Fernando Conrado Abrao and Igor Renato Louro Bruno de Abreu and Roberto Odebrecht Rocha and Felipe Dourado Munhoz and João Henrique Godoy Rodrigues and Bernardo Nogueira Batista},
title = {Interaction between treatment delivery delay and stage on the mortality from non-small cell lung cancer},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {5},
year = {2018},
keywords = {},
abstract = {Background: The aim of this study is to evaluate the interaction between treatment delay and stage on the mortality from non-small cell lung cancer (NSCLC).
Methods: We performed a survival analysis in a cohort of patients admitted to the reference cancer center. The following data were collected: age, gender, smoking status, tumor staging, type of lung cancer, and time from the date when the patient was diagnosed with cancer to the starting date of effective treatment. Univariable and multivariable Cox proportional hazard models were used to investigate the association between potential confounders identified during the study design. After the final adjusted model was determined, tests for interaction among all predictors were performed.
Results: Inclusion criteria were met by 359 patients. In the adjusted analysis, delayed treatment delivery was a protective factor for the risk of death, with a crude hazard ratio (HR) =0.75 (0.59–0.97; P=0.02) and an adjusted HR =0.59 (0.46–0.77; P},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/21410}
}